{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:01:05Z","timestamp":1793217665106,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.03.023","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T02:51:46Z","timestamp":1585795906000},"page":"3671-3681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Development of a multivalent enterovirus subunit vaccine based on immunoinformatic design principles for the prevention of HFMD"],"prefix":"10.1016","volume":"38","author":[{"given":"Huixiong","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.023_b0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/14760584.2018.1510326","article-title":"Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease","volume":"17","author":"Fang","year":"2018","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2020.03.023_b0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MOP.0000000000000303","article-title":"Enteroviruses in the early 21st century: new manifestations and challenges","volume":"28","author":"Lugo","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.vaccine.2020.03.023_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2019.07.012","article-title":"High proportion of coxsackievirus B3 genotype A in hand, foot and mouth disease in Zhenjiang, China, 2011\u20132016","volume":"87","author":"Fu","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.023_b0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12929-019-0573-2","article-title":"The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region","volume":"26","author":"Puenpa","year":"2019","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2020.03.023_b0030","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1080\/21645515.2015.1049780","article-title":"Is a multivalent hand, foot, and mouth disease vaccine feasible?","volume":"11","author":"Klein","year":"2015","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2020.03.023_b0035","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1016\/j.vaccine.2014.08.064","article-title":"Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases","volume":"32","author":"Liu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.023_b0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00430-016-0465-y","article-title":"Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy","volume":"205","author":"Aswathyraj","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0045","article-title":"Protective efficacies of formaldehyde-inactivated whole-virus vaccine and antivirals in a murine model of coxsackievirus A10 infection","volume":"91","author":"Zhang","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.03.023_b0055","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.03.023_b0060","doi-asserted-by":"crossref","first-page":"e79599","DOI":"10.1371\/journal.pone.0079599","article-title":"The cross-neutralizing activity of enterovirus 71 subgenotype C4 vaccines in healthy chinese infants and children","volume":"8","author":"Mao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.023_b0065","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.03.023_b0070","doi-asserted-by":"crossref","first-page":"e49973","DOI":"10.1371\/journal.pone.0049973","article-title":"Immunological and biochemical characterization of coxsackie virus A16 viral particles","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.023_b0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.vaccine.2020.03.023_b0080","doi-asserted-by":"crossref","first-page":"e1000048","DOI":"10.1371\/journal.pcbi.1000048","article-title":"A Systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach","volume":"4","author":"Sette","year":"2008","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00251-004-0709-7","article-title":"Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles","volume":"56","author":"Reche","year":"2004","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2020.03.023_b0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","article-title":"Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes","volume":"63","author":"Greenbaum","year":"2011","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2020.03.023_b0095","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/bioinformatics\/btq324","article-title":"EpiTOP-a proteochemometric tool for MHC class II binding prediction","volume":"26","author":"Dimitrov","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2020.03.023_b0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol Direct"},{"key":"10.1016\/j.vaccine.2020.03.023_b0105","doi-asserted-by":"crossref","first-page":"263952","DOI":"10.1155\/2013\/263952","article-title":"Prediction of IL4 inducing peptides","volume":"2013","author":"Dhanda","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0110","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2020.03.023_b0115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Sequence analysis Gapped sequence alignment using artificial neural networks : application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2020.03.023_b0120","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.vaccine.2004.02.005","article-title":"Prediction of CTL epitopes using QM, SVM and ANN techniques","volume":"22","author":"Bhasin","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.023_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2020.03.023_b0130","doi-asserted-by":"crossref","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0135","doi-asserted-by":"crossref","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.023_b0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/1471-2105-8-361","article-title":"Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines","volume":"8","author":"Bui","year":"2007","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2020.03.023_b0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2105-6-132","article-title":"Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method","volume":"6","author":"Peters","year":"2005","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2020.03.023_b0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.meegid.2017.12.008","article-title":"Structural vaccinology considerations for in silico designing of a multi-epitope vaccine","volume":"58","author":"Negahdaripour","year":"2018","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0155","doi-asserted-by":"crossref","first-page":"e104351","DOI":"10.1371\/journal.pone.0104351","article-title":"A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.023_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2020.03.023_b0165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/nar\/gki396","article-title":"SCRATCH: A protein structure and structural feature prediction server","volume":"33","author":"Cheng","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2020.03.023_b0170","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP vol 2-A server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J Mol Model"},{"key":"10.1016\/j.vaccine.2020.03.023_b0175","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","article-title":"SOLpro: Accurate sequence-based prediction of protein solubility","volume":"25","author":"Magnan","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2020.03.023_b0180","first-page":"531","article-title":"Protein identification and analysis tools in the ExPASy server","volume":"112","author":"Wilkins","year":"1999","journal-title":"Meth Mol Biol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/nar\/gkt381","article-title":"Scalable web services for the PSIPRED Protein Analysis Workbench","volume":"41","author":"Buchan","year":"2013","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2020.03.023_b0190","first-page":"e3259","article-title":"A protocol for computer-based protein structure and function prediction","author":"Roy","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2020.03.023_b0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1471-2105-14-346","article-title":"Disulfide by Design 2.0: A web-based tool for disulfide engineering in proteins","volume":"14","author":"Craig","year":"2013","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2020.03.023_b0200","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: Protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2020.03.023_b0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2020.03.023_b0210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by C\u03b1 geometry: \u03c6, \u03c8 and C\u03b2 deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins Struct Funct Genet"},{"key":"10.1016\/j.vaccine.2020.03.023_b0215","doi-asserted-by":"crossref","first-page":"e1002829","DOI":"10.1371\/journal.pcbi.1002829","article-title":"Reliable B cell epitope predictions: impacts of method development and improved benchmarking","volume":"8","author":"Kringelum","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/prot.25219","article-title":"New additions to the ClusPro server motivated by CAPR","volume":"85","author":"Vajda","year":"2017","journal-title":"Proteins"},{"key":"10.1016\/j.vaccine.2020.03.023_b0225","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Ra","year":"2011","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.vaccine.2020.03.023_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.023_b0235","article-title":"A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth Disease (HFMD)","volume":"18","author":"World Health Organization","year":"2011","journal-title":"World Heal. Organ."},{"key":"10.1016\/j.vaccine.2020.03.023_b0240","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1128\/jvi.71.3.2292-2302.1997","article-title":"A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen","volume":"71","author":"An","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.03.023_b0245","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1209368","article-title":"Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold","volume":"334","author":"Azoitei","year":"2011","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:48Z","timestamp":1759401768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20303765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":49,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20303765"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a multivalent enterovirus subunit vaccine based on immunoinformatic design principles for the prevention of HFMD","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}